AU Patent

AU2006322187A1 — Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors

Assigned to Novartis AG · Expires 2007-06-14 · 19y expired

What this patent protects

Patent listed against Retevmo.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006322187A1
Jurisdiction
AU
Classification
—
Expires
2007-06-14
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.